<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39385233</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2523-3106</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Advances in rheumatology (London, England)</Title><ISOAbbreviation>Adv Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil.</ArticleTitle><Pagination><StartPage>78</StartPage><MedlinePgn>78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s42358-024-00418-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">SARS-CoV-2 infection has become a major international issue, not only from a medical point of view, but also social, economic and political. Most of the available information comes from the United States, Europe, and China, where the population and the socioeconomic status are very different from Latin American countries. This study evaluates the effect of regional socioeconomic characteristics on mortality due SARS-CoV-2 infection in patients with immune-mediated rheumatic diseases (IMRD) from Argentina, Mexico and Brazil.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from three national registries, SAR-COVID (Argentina), CMR-COVID (Mexico) and ReumaCoV-Brasil (Brazil), were combined. Adult IMRD patients with SARS-CoV-2 infection were recruited. National data for each province/state, including population density, number of physicians per inhabitant, income, unemployment, GINI index, Municipal Human Development Index (MHDI), stringency index, vaccination rate and most frequent viral strains per period were assessed as risk factors for mortality due to COVID-19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 4744 patients were included, 2534 (53.4%) from SAR-COVID, 1166 (24.6%) from CMRCOVID and 1044 (22.0%) from ReumaCoV-Brasil. Mortality due to COVID-19 was 5.4%. In the multivariable analysis, higher number of physicians per 1000 inhabitants and being infected during the vaccination period of each country were associated with lower mortality. After adjustment for socioeconomic factors, there was no association with country of residence and mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings corroborate the complex interplay between socioeconomic factors, rheumatic disease activity, and regional disparities as determinants of death due to COVID-19 in Argentina, Brazil and Mexico. Thus, this research provides valuable insights for guiding public health policies and clinical practice in the ongoing fight against the COVID-19 pandemic.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinez-Martinez</LastName><ForeName>Marco Ulises</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Hospital General de Subzona No. 9, Instituto Mexicano del Seguro Social, San Luis, Potosí, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isnardi</LastName><ForeName>Carolina Ayelen</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Research Unit, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alpizar-Rodriguez</LastName><ForeName>Deshiré</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research Unit, Colegio Mexicano de Reumatología, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pons-Estel</LastName><ForeName>Guillermo Javier</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Research Unit, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virasoro</LastName><ForeName>Belén María</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Research Unit, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfaro</LastName><ForeName>María Agustina</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Research Unit, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petkovic</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Investigator of the SAR-COVID Registry, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanatorio Petkovic, Tunuyán, Mendoza, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana</LastName><ForeName>Rosana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Investigator of the SAR-COVID Registry, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>6Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Santa Fe, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berbotto</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Investigator of the SAR-COVID Registry, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanatorio Británico Rosario, Chief of the Rheumatology Service, Rosario, Santa Fe, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas</LastName><ForeName>María Jezabel Haye</ForeName><Initials>MJH</Initials><AffiliationInfo><Affiliation>Investigator of the SAR-COVID Registry, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Reumatologa CEMMA, Universidad Nacional de La Rioja, La Rioja, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ornella</LastName><ForeName>Sofía</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Investigator of the SAR-COVID Registry, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HIGA San Martin, La Plata, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pera</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Investigator of the SAR-COVID Registry, Argentine Society of Rheumatology, CABA, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Angel C Padilla, San Miguel de Tucuman, Tucuman, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colunga-Pedraza</LastName><ForeName>Iris Jazmín</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario José Eleuterio González, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irazoque-Palazuelos</LastName><ForeName>Fedra</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación y Tratamiento Reumatológico S.C., Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Cordero</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina y Ciencias Biomédicas, Universidad Autónoma de Chihuahua, Chihuahua, Private Practice Rheumatology, Chihuahua, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Reyna</LastName><ForeName>Tatiana S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veloz-Aranda</LastName><ForeName>Jose Antonio</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Regional ISSSTE, Leon, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skinner-Taylor</LastName><ForeName>Cassandra Michele</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario José Eleuterio González, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juárez-Mora</LastName><ForeName>Ingrid Maribel</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Internal Medicine, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silveira</LastName><ForeName>Luis H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Investigator of CMR-COVID Registry, Mexican College of Rheumatology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Nacional de Cardiología, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Claudia Diniz Lopes</ForeName><Initials>CDL</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>Ricardo Machado</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakehasi</LastName><ForeName>Adriana Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais, Alfredo Balena Avenue, 190, Belo Horizonte, Minas Gerais, CEP: 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomides</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniCEUB, Brasília, Distrito Federal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Reis-Neto</LastName><ForeName>Edgard Torres</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pileggi</LastName><ForeName>Gecilmara Salviato</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Gilda Aparecida</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais, Alfredo Balena Avenue, 190, Belo Horizonte, Minas Gerais, CEP: 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Mota</LastName><ForeName>Licia Maria Henrique</ForeName><Initials>LMH</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Sciences, Medical School, Universidade de Brasília, Brasília, Distrito Federal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinheiro</LastName><ForeName>Marcelo Medeiros</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calderaro</LastName><ForeName>Débora Cerqueira</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-5535-3223</Identifier><AffiliationInfo><Affiliation>ReumaCoV-Brasil, Brazilian Society of Rheumatology, São Paulo, Brazil. dccalderaro@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais, Alfredo Balena Avenue, 190, Belo Horizonte, Minas Gerais, CEP: 30130-100, Brazil. dccalderaro@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Sociedade Brasileira de Reumatologia</GrantID><Agency>Sociedade Brasileira de Reumatologia</Agency><Country /></Grant><Grant><GrantID>International League of Associations for Rheumatology</GrantID><Agency>International League of Associations for Rheumatology</Agency><Country /></Grant><Grant><GrantID>Colegio Mexicano de Reumatologia</GrantID><Agency>Colegio Mexicano de Reumatologia</Agency><Country /></Grant><Grant><GrantID>Colegio Mexicano de Reumatologia</GrantID><Agency>Colegio Mexicano de Reumatologia</Agency><Country /></Grant><Grant><GrantID>National Council for Scientific and Technological Development</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country /></Grant><Grant><GrantID>Sociedad Argentina de Reumatologia</GrantID><Agency>Sociedad Argentina de Reumatologia</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Adv Rheumatol</MedlineTA><NlmUniqueID>101734172</NlmUniqueID><ISSNLinking>2523-3106</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="Y">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014478" MajorTopicYN="N">Unemployment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011156" MajorTopicYN="N">Population Density</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Immune-mediated rheumatic diseases</Keyword><Keyword MajorTopicYN="N">Regional socioeconomic factors</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385233</ArticleId><ArticleId IdType="doi">10.1186/s42358-024-00418-3</ArticleId><ArticleId IdType="pii">10.1186/s42358-024-00418-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zsichla L, Müller V. Risk factors of severe COVID-19: a review of host, viral and environmental factors. Viruses. 2023;15:175. https://doi.org/10.3390/v15010175 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010175</ArticleId><ArticleId IdType="pubmed">36680215</ArticleId><ArticleId IdType="pmc">9863423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Ma Y, Xu S, Liu H, Chen Y, Yang H, Shao M, Xu W, Kong J, Chen L, Xu S, Shuai Z, Pan F. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis. Clin Rheumatol. 2022;41(7):2213–23. https://doi.org/10.1007/s10067-022-06087-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06087-1</ArticleId><ArticleId IdType="pubmed">35352217</ArticleId><ArticleId IdType="pmc">8964246</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet. COVID-19 in Latin America-emergency and opportunity. Lancet. 2021;398(10295):93. https://doi.org/10.1016/S0140-6736(21)01551-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01551-8</ArticleId><ArticleId IdType="pubmed">34246349</ArticleId><ArticleId IdType="pmc">8266269</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRotta J, Escobar O, Ávila-Aguero ML, Torres JP, Sini de Almeida R, Morales GDC, et al. COVID-19 in Latin America: a snapshot in Time and the Road ahead. Infect Dis Ther. 2023;12:389–410. https://doi.org/10.1007/s40121-022-00748-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-022-00748-z</ArticleId><ArticleId IdType="pubmed">36633818</ArticleId><ArticleId IdType="pmc">9835740</ArticleId></ArticleIdList></Reference><Reference><Citation>Izadi Z, Gianfrancesco MA, Schmajuk G, Jacobsohn L, Katz P, Rush S, et al. COVID-19 global Rheumatology Alliance Registry. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study. Lancet Rheumatol. 2022;4:e603–13. https://doi.org/10.1016/S2665-9913(22)00192-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(22)00192-8</ArticleId><ArticleId IdType="pubmed">35909441</ArticleId><ArticleId IdType="pmc">9313519</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnardi CA, Alpizar-Rodriguez D, Calderaro DC, Marques CDL, Pons-Estel GJ, Xavier RM, et al. Factors Associated with mortality in patients with Immune-mediated rheumatic diseases and COVID-19 from Latin America: Data from Argentina, Mexico, and Brazil. J Clin Rheumatol. 2024;30:e9–17. https://doi.org/10.1097/RHU.0000000000002038 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000002038</ArticleId><ArticleId IdType="pubmed">37936271</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques C, Kakehasi AM, Gomides APM, Paiva EDS, Dos Reis Neto ET, Pileggi GCS, et al. A Brazilian cohort of patients with Immuno-mediated chronic inflammatory diseases infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): protocol for a prospective, observational study. JMIR Res Protoc. 2020;9:e24357. https://doi.org/10.2196/24357 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/24357</ArticleId><ArticleId IdType="pubmed">33156812</ArticleId><ArticleId IdType="pmc">7744142</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnardi CA, Soriano ER, Graf C, de la Vega MC, Pons-Estel BA, et al. Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry). J Clin Rheumatol. 2023;29:68–77. https://doi.org/10.1097/RHU.0000000000001903 . E.</Citation></Reference><Reference><Citation>Martínez-Martínez MU, Irazoque-Palazuelos F, Rodriguez-Reyne TS, et al. On behalf of Mexican study group of COVID-19 in rheumatic diseases. Mortality of COVID-19 in patients with rheumatic diseases: comparison to the general population in Mexico. Ann Rheum Dis. 2021;80(Suppl 1):905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-eular.3447</ArticleId></ArticleIdList></Reference><Reference><Citation>World Bank Data Bank. [Accessed 2024 August 06]. https://databank.worldbank.org/metadataglossary/gender-statistics/series/SI.POV.GINI</Citation></Reference><Reference><Citation>COVID-Stringency index: Global Change Data Lab; 2024 [Accessed 2024 March 20]. https://ourworldindata.org/covid-stringency-index#:~:text=The%20nine%20metrics%20used%20to,movements%3B%20and%20international%20travel%20controls</Citation></Reference><Reference><Citation>Ribeiro KB, Ribeiro AF, Veras MASM, de Castro MC. Social inequalities and COVID-19 mortality in the city of São Paulo, Brazil. Int J Epidemiol. 2021;50:732–42. https://doi.org/10.1093/ije/dyab022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab022</ArticleId><ArticleId IdType="pubmed">33657223</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge RW, Lewer D, Katikireddi SV, Mathur R, Pathak N, Burns R, et al. Black, Asian and Minority ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Wellcome Open Res. 2020;5:88. https://doi.org/10.12688/wellcomeopenres.15922.2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15922.2</ArticleId><ArticleId IdType="pubmed">32613083</ArticleId><ArticleId IdType="pmc">7317462</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Calderón-Villarreal A, Bojorquez I, Vera Hernández C, Schriger DL, Tovar Hirashima E. Excess out-of-hospital mortality and declining Oxygen Saturation: the Sentinel Role of Emergency Medical Services Data in the COVID-19 Crisis in Tijuana, Mexico. Ann Emerg Med. 2020;76(4):413–26. https://doi.org/10.1016/j.annemergmed.2020.07.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2020.07.035</ArticleId><ArticleId IdType="pubmed">33012377</ArticleId><ArticleId IdType="pmc">7377712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sy KTL, White LF, Nichols BE. Population density and basic reproductive number of COVID-19 across United States counties. PLoS ONE. 2021;16:e0249271. https://doi.org/10.1371/journal.pone.0249271 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249271</ArticleId><ArticleId IdType="pubmed">33882054</ArticleId><ArticleId IdType="pmc">8059825</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health. 2021;20:248. https://doi.org/10.1186/s12939-021-01582-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01582-4</ArticleId><ArticleId IdType="pubmed">34819081</ArticleId><ArticleId IdType="pmc">8611382</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-García A, et al. COVID-19 global Rheumatology Alliance. SARS-CoV-2 infection and COVID-19 outcomes in Rheumatic diseases: a systematic literature review and Meta-analysis. Arthritis Rheumatol. 2022;74:766–75. https://doi.org/10.1002/art.42030 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42030</ArticleId><ArticleId IdType="pubmed">34807517</ArticleId><ArticleId IdType="pmc">9011807</ArticleId></ArticleIdList></Reference><Reference><Citation>Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, et al. COVID-19 global Rheumatology Alliance. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021;80:930–42. https://doi.org/10.1136/annrheumdis-2020-219498 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219498</ArticleId><ArticleId IdType="pubmed">33504483</ArticleId></ArticleIdList></Reference><Reference><Citation>Boserup B, McKenney M, Elkbuli A. Disproportionate impact of COVID-19 pandemic on racial and ethnic minorities. Am Surg. 2020;86(12):1615–22. https://doi.org/10.1177/0003134820973356 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003134820973356</ArticleId><ArticleId IdType="pubmed">33231496</ArticleId><ArticleId IdType="pmc">7691116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HN, Lan KF, Nkyekyer E, Neme S, Pierre-Louis M, Chew L, et al. Assessment of disparities in COVID-19 testing and Infection across Language Groups in Seattle, Washington. JAMA Netw Open. 2020;3(9):e2021213. https://doi.org/10.1001/jamanetworkopen.2020.21213 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.21213</ArticleId><ArticleId IdType="pubmed">32970156</ArticleId><ArticleId IdType="pmc">7516622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman-Cribbin W, Tuminello S, Flores RM, Taioli E. Disparities in COVID-19 testing and positivity in New York City. Am J Prev Med. 2020;59:326–32. https://doi.org/10.1016/j.amepre.2020.06.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2020.06.005</ArticleId><ArticleId IdType="pubmed">32703702</ArticleId><ArticleId IdType="pmc">7316038</ArticleId></ArticleIdList></Reference><Reference><Citation>Loomba RS, Aggarwal G, Aggarwal S, Flores S, Villarreal EG, Farias JS, et al. Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States. Ann Med. 2021;53:151–9. https://doi.org/10.1080/07853890.2020.1840620 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1840620</ArticleId><ArticleId IdType="pubmed">33138653</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza WM, Buss LF, Candido DDS, Carrera JP, Li S, Zarebski AE, et al. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nat Hum Behav. 2020;4:856–65. https://doi.org/10.1038/s41562-020-0928-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-020-0928-4</ArticleId><ArticleId IdType="pubmed">32737472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ríos V, Denova-Gutiérrez E, Barquera S. Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico. PLoS ONE. 2022;17:e0264137. https://doi.org/10.1371/journal.pone.0264137 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264137</ArticleId><ArticleId IdType="pubmed">35192660</ArticleId><ArticleId IdType="pmc">8863291</ArticleId></ArticleIdList></Reference><Reference><Citation>Chávez-Almazán LA, Díaz-González L, Rosales-Rivera M. Socioeconomic determinants of health and COVID-19 in Mexico. Gac Med Mex. 2022;158:3–10. English. https://doi.org/10.24875/GMM.M22000633</Citation></Reference><Reference><Citation>Fortuna-Reyna BJ, Peláez-Ballestas I, García-Rodríguez F, Faugier-Fuentes E, Mendieta-Zerón S, Villarreal-Treviño AV, et al. Psychosocial and economic impact of rheumatic diseases on caregivers of Mexican children. Pediatr Rheumatol Online J. 2021;19(1):30. https://doi.org/10.1186/s12969-021-00524-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00524-2</ArticleId><ArticleId IdType="pubmed">33731150</ArticleId><ArticleId IdType="pmc">7967951</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinsete AM, Woo JMP, Rubinstein TB. Disparities in Pediatric Rheumatic diseases. Rheum Dis Clin North Am. 2022;48:183–98. https://doi.org/10.1016/j.rdc.2021.09.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2021.09.014</ArticleId><ArticleId IdType="pubmed">34798946</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnardi CA, Roberts K, Saurit V, Petkovic I, Báez RM, Quintana R, et al. A. R.–COVID Registry investigators. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry. Clin Rheumatol. 2023;42:563–78. https://doi.org/10.1007/s10067-022-06393-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06393-8</ArticleId><ArticleId IdType="pubmed">36201124</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi AM, Castillo Salgado C, Sarrouf EB, Zamora RJ, Irurzun AM, Islam N. Socioeconomic inequities of COVID-19 mortality in vulnerable Comunas of the City of Buenos Aires. Sci Rep. 2023;13(1):13642. https://doi.org/10.1038/s41598-023-40911-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-40911-1</ArticleId><ArticleId IdType="pubmed">37608084</ArticleId><ArticleId IdType="pmc">10444792</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner MS, Trotta A, Bilal U, Acharya B, Quick H, Pacífico N, et al. Social inequalities and COVID-19 mortality between neighborhoods of Bariloche city, Argentina. Int J Equity Health. 2023;22:198. https://doi.org/10.1186/s12939-023-02019-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-023-02019-w</ArticleId><ArticleId IdType="pubmed">37770868</ArticleId><ArticleId IdType="pmc">10537962</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira FAC, Filho FMHS, de Azevedo AR, de Oliveira GL, Flores-Ortiz R, Valencia LIO, et al. Profile of COVID-19 in Brazil-risk factors and socioeconomic vulnerability associated with disease outcome: retrospective analysis of population-based registers. BMJ Glob Health. 2022;7:e009489. https://doi.org/10.1136/bmjgh-2022-009489 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2022-009489</ArticleId><ArticleId IdType="pubmed">36517111</ArticleId></ArticleIdList></Reference><Reference><Citation>Millán-Guerrero RO, Caballero-Hoyos R, Monárrez-Espino J. Poverty and survival from COVID-19 in Mexico. J Public Health (Oxf). 2021;43:437–44. https://doi.org/10.1093/pubmed/fdaa228 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdaa228</ArticleId><ArticleId IdType="pubmed">33367803</ArticleId></ArticleIdList></Reference><Reference><Citation>Revollo-Fernández D, Rodríguez-Tapia L, Medina-Rivas C, Morales-Novelo JA. Socio-economic determinants of COVID-19 in Mexico. Public Health. 2022;207:28–30. https://doi.org/10.1016/j.puhe.2022.03.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.03.011</ArticleId><ArticleId IdType="pubmed">35486980</ArticleId></ArticleIdList></Reference><Reference><Citation>Putrik P, Ramiro S, Orueta JF, Keszei A, Alonso Moran E, Nuño Solinis R, et al. Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons. Clin Exp Rheumatol. 2018;36:589–94. Epub 2018 Jan 31.</Citation><ArticleIdList><ArticleId IdType="pubmed">29465359</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikiphorou E, Alpizar-Rodriguez D, Gastelum-Strozzi A, Buch M, Peláez-Ballestas I. Syndemics &amp; syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era. Rheumatology (Oxford). 2021;60:2040–5. https://doi.org/10.1093/rheumatology/keaa840 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa840</ArticleId><ArticleId IdType="pubmed">33496334</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnardi C, de Abreu P, Terán VR, De la Veja MC, Alfaro MA, Gamba J, et al. Global Rheumatol. 2024;5. Patterns Of Use Of Biologic Dmards And Small Molecules In Patients With Inflammatory Arthritis: Combined Data From Four Countries Of Latin America. Abstracts PANLAR 2024, Special Issue. https://doi.org/10.46856/grp.28.e189</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>